Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ishina Balwani
Institution:
Intellia Therapeutics (United States)
Observed institutions:
Jaypee Institute of Information Technology,
University of Michigan,
Intellia Therapeutics (United States)
ORCID:
0009-0000-7773-5222
Observed ORCID:
0009-0000-7773-5222
OpenAlex ID:
A5025202178
Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy
2018
·
Rui Kuai
, Xiaoqi Sun
, et al.
·
Journal of Controlled Release
·
145
PDF
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function
2022
·
Eliana Ruggiero
, Erica Carnevale
, et al.
·
Science Translational Medicine
·
58
PDF
Role of phytase producing microorganisms towards agricultural sustainability
2017
·
Ishina Balwani
, Kashyapi Chakravarty
, et al.
·
Biocatalysis and Agricultural Biotechnology
·
26
A differentiated and durable allogeneic strategy applicable to cell therapies
2025
·
Utsav Jetley
, Ishina Balwani
, et al.
·
Cytotherapy
·
6
NTLA5001, a T Cell Product Candidate with CRISPR-Based Targeted Insertion of a High-Avidity, Natural, WT1-Specific TCR, Shows Efficacy in In Vivo Models of AML and ALL
2020
·
Eliana Ruggiero
, Dai Liu
, et al.
·
Blood
·
2
A Novel Strategy for Off-the-Shelf T Cell Therapy Which Evades Allogeneic T Cell and NK Cell Rejection
2021
·
Yong Zhang
, Surbhi Goel
, et al.
·
Blood
·
1
Engineering antigen-driven co-stimulation and T helper cell activity into TCR-T cells with CD8-41BB fusion receptors enhances anti-tumor activity
2026
·
Ivy Dutta
, Justin Oh
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
388 Engineering co-stimulation into TCR-T cells via a CD8–41BB fusion receptor enhances efficacy and durability in preclinical models of heme and solid tumor malignancies
2024
·
Aaron Prodeus
, Ivy Dutta
, et al.
·
Journal for ImmunoTherapy of Cancer
342 Improving TCR-T cell function against solid tumors with immune enhancing edits
2023
·
Ishina Balwani
, Nachiket Narendra Shevale
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
173 An in vivo CRISPR/Cas9 screening platform to identify T cell enhancing edits in distinct solid tumor microenvironments
2020
·
Amy Becker
, Troy Luster
, et al.
·
Journal for ImmunoTherapy of Cancer
Abstract 5574: In vivo model development for immune cell-based therapeutics
2020
·
Elizabeth McMichael
, Utsav Jetley
, et al.
·
Cancer Research
Stimulation of NKT Cells with a Novel Nano-Delivery System Loaded with Alpha-Galactosylcermide
2016
·
Ishina Balwani
Show more works
View as search
Works count:
12
Citation count:
238
H-index:
4
I10-index:
3
Year
Topic
Type